Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades22,458
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
AZN Company
Research
AZN Company
Timeline
Share Price Information for Astrazeneca (AZN)
Last checked at -
Last checked at 
Intraday Astrazeneca Share Chart
Astrazeneca News
Shore Capital lowers AstraZeneca to 'hold'
(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings out...
LONDON MARKET MIDDAY: Stocks edge lower ahead of US CPI data
(Alliance News) - Stock prices in London were modestly lower at midday on Friday, with sentiment cautious ahead of US inflation data and the Munich Se...
LONDON BROKER RATINGS: Bernstein, Barclays and Deutsche lower Relx
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:
AstraZeneca rises on positive trial results for asthma therapy
(Alliance News) - Astrazeneca on Friday hailed positive results from a phase-three trial of its asthma treatment breztri aerosphere.
LONDON BRIEFING: NatWest results ahead of forecasts, ups dividend 51%
(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data ...
Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant
LONDON, Feb 12 (Reuters) - French drugmaker Sanofi ousted CEO Paul Hudson on Thursday, ending a six-year tenure marked by a stalled drive to replace...
LONDON BROKER RATINGS: Exane BNP and HSBC cut BP; JPM likes Barclays
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:
Pharma companies left out of Trump's drug-pricing deals look for way in
SAN FRANCISCO, Feb 11 (Reuters) - Some pharmaceutical companies not targeted by President Donald Trump for agreements to lower their U.S. drug pricin...
Follow the stocks
